References
- 4,4′-Methylenedianiline and its dihydrochloride. IARC Monogr Eval Carcinog Risk Chem Hum 1986; 39: 347–365
- Fukushima S, Shibata M, Hibino T, Yoshimura T, Hirose M, Ito N. Intrahepatic bile duct proliferation induced by 4,4′diaminodiphenylmethane in rats. Toxicol Appl Pharmacol 1979; 48: 145–155
- Beard R R, Noe JT. Aromatic nitro and amine compounds. Patty's Industrial Hygiene and Toxicology, GD Clayton, FE Clayton. John Wiley & Sons, New York 1981; 2413–2489
- McQueen C A, Williams GM. Review of the genotoxicity and carcinogenicity of 4,4′-methylenedianiline and 4,4′-methylene-bis-2-chloroaniline. Mutat Res 1990; 239: 133–142
- Parodi S, Taningher M, Russo P, Pala M, Tamaro M, Monti Bragadin C. DNA-damaging activityin vivo and bacterial mutagenicity of sixteen aromatic amines and azo-derivatives, as related quantitatively to their carcinogenicity. Carcinogenesis 1981; 2: 1317–1326
- Schoental R. Carcinogenic and chronic effects of 4,4′-diaminodiphenylmethane, an epoxyresin hardener. Nature 1968; 219: 1162–1163
- Liss G M, Guirguis SS. Follow-up of a group of workers intoxicated with 4,4′-methylenedianiline. Am J Ind Med 1994; 26: 117–124
- Selden A, Berg P, Jakobsson R, De Laval J. Methylene dianiline: assessment of exposure and cancer morbidity in power generator workers. Int Arch Occup Environ Health 1992; 63: 403–408
- Bastian PG. Occupational hepatitis caused by methylenedianiline. Med J Aust 1984; 141: 533–535
- LeVine MJ. Occupational photosensitivity to diaminodiphenylmethane. Contact Dermatitis 1983; 9: 488–490
- McGill D B, Motto JD. An industrial outbreak of toxic hepatitis due to methylenedianiline. N Engl J Med 1974; 291: 278–282
- Leong B K, Lund J E, Groehn J A. Retinopathy from inhaling 4,4′-methylenedianiline aerosols. Fundam Appl Toxicol 1987; 9: 645–658
- Van Joost T, Heule F, De Boer J. Sensitization to methylenedianiline and para-structures. Contact Dermatitis 1987; 16: 246–248
- Roy C W, McSorley P D, Syme IG. Methylene dianiline: a new toxic cause of visual failure with hepatitis. Hum Toxicol 1985; 4: 61–66
- Kopelman H, Scheuer P J, Williams R. The liver lesion of the Epping Jaundice. Q J Med 1966; 35: 553–564
- Kopelman H, Robertson M H, Sanders P G, Ash I. The Epping Jaundice. Br Med J 1966; 1: 514–516
- De Man RA. [Morbidity and mortality caused by use of ecstasy]. Ned Tijdschr Geneeskd 1994; 138: 1850–1855
- Forrest A R, Galloway J H, Marsh I D, Strachan G A, Clark JC. A fatal overdose with 3,4-methylenedioxyamphetamine derivatives. Forensic Sci Int 1994; 64: 57–59
- Walsh T, Carmichael R, Chestnut J. A hyperthermic reaction to ‘ecstasy’. Br J Hosp Med 1994; 51: 476
- Barrett P J, Taylor GT. ‘Ecstasy’ ingestion: a case report of severe complications. J R Soc Med 1993; 86: 233–234
- Fahal I H, Sallomi D F, Yaqoob M, Bell GM. Acute renal failure after ecstasy. BMJ 1992; 305: 29
- Henry J A, Jeffreys K J, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”). Lancet 1992; 340: 384–387
- Jones A L, Jarvie D R, McDermid G, Proudfoot AT. Hepatocellular damage following amphetamine intoxication. J Toxicol Clin Toxicol 1994; 32: 435–444
- Tillmann H L, Van Pelt F NAM, Choefl C, Wagner S, Maschek H, Manns MP. Severe hepatitis and prolonged cholestasis following repeated ingestion of ecstasy. X. International Liver symposium. Acute and chronic liver disease. Molecular biology and clinic, Basel 1995, Abstrakt 267
- Fairbanks VF. Blue gods, blue oil, and blue people. Mayo Clin Proc 1994; 69: 889–892
- Bailie M B, Hewett J A, Schultze A E, Roth RA. Methylene dianiline hepatotoxicity is not leukocytedependent. Toxicol Appl Pharmacol 1994; 124: 25–30
- Kanz M F, Kaphalia L, Kaphalia B S, Romagnoli E, Ansari GA. Methylene dianiline: Acute toxicity and effects on biliary function. Toxicol Appl Pharmacol 1992; 117: 88–97
- Cocker J, Nutley B P, Wilson HK. A biological monitoring assessment of exposure to methylene dianiline in manufactures and users. Occup Environ Med 1994; 51: 519–522
- De Man R A, Wilson J HP, Tjen H SLM. [Acute liver failure due to methylenedioxymethamphetamine (ecstasy)]. Ned Tijdschr Geneeskd 1993; 137: 727–729
- Lamb J C, Huff J E, Haseman J K, Murthy A SK, Lilja H. Carcinogenesis studies of 4,4′-methylenedianiline dihydrochloride given in drinking water to F344/N rats and B6C3F1 mice. J Toxicol Environ Health 1986; 18: 325–337
- Brunmark P, Brunze M, Skerfving S, Skarping G. Biomonitoring of 4,4′-methylene dianiline by measurement in hydrolysed urine and plasma after epicutaneous exposure in humans. Int Arch Occup Environ Health 1995; 67: 95–100